Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Shares Outstanding (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Shares Outstanding for 10 consecutive years, with $3.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 140.47% to $3.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.6 million, a 140.47% increase, with the full-year FY2025 number at $3.6 million, changed N/A from a year prior.
  • Shares Outstanding was $3.6 million for Q4 2025 at Ekso Bionics Holdings, up from $2.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $14.2 million in Q3 2023 to a low of $990000.0 in Q4 2023.
  • A 5-year average of $7.7 million and a median of $8.1 million in 2021 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: grew 2.81% in 2022, then surged 140.47% in 2025.
  • Ekso Bionics Holdings' Shares Outstanding stood at $12.7 million in 2021, then grew by 4.26% to $13.2 million in 2022, then tumbled by 88.79% to $1.5 million in 2024, then soared by 140.47% to $3.6 million in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Shares Outstanding are $3.6 million (Q4 2025), $2.6 million (Q3 2025), and $1.9 million (Q1 2025).